Form EFFECT CONDUIT PHARMACEUTICALS
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 6, 2024 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion
- New Reframe Data: July 4th Was America's Biggest Drinking Day of 2026 — Bigger Than Christmas
- MKTX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of MarketAxess to Intercontinental Exchange
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
